Education
About Us
Working with TipRanks
Follow Us
AstraZeneca Pharma India Limited (IN:ASTRAZEN)
:ASTRAZEN
Total Valuation
AstraZeneca Pharma India Limited has a market cap or net worth of ₹251.77B. The enterprise value is ―.
Market Cap₹251.77B
Enterprise Value―
Share Statistics
AstraZeneca Pharma India Limited has 25,000,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding25,000,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
AstraZeneca Pharma India Limited’s return on equity (ROE) is 0.23 and return on invested capital (ROIC) is 45.54%.
Return on Equity (ROE)0.23
Return on Assets (ROA)0.15
Return on Invested Capital (ROIC)45.54%
Return on Capital Employed (ROCE)0.62
Revenue Per Employee―
Profits Per Employee―
Employee Count―
Asset Turnover1.20
Inventory Turnover2.95
Valuation Ratios
The current PE Ratio of AstraZeneca Pharma India Limited is 80.50. AstraZeneca Pharma India Limited’s PEG ratio is 11.90.
PE Ratio80.50
PS Ratio0.00
PB Ratio31.20
Price to Fair Value18.26
Price to FCF2.86K
Price to Operating Cash Flow2.86K
PEG Ratio11.90
Income Statement
In the last 12 months, AstraZeneca Pharma India Limited had revenue of 12.96B and earned 1.62B in profits. Earnings per share was 64.60.
Revenue12.96B
Gross Profit6.22B
Operating Income4.47B
Pretax Income2.20B
Net Income1.62B
EBITDA2.36B
Earnings Per Share (EPS)64.60
Cash Flow
In the last 12 months, operating cash flow was 147.57M and capital expenditures 0.00, giving a free cash flow of 147.57M billion.
Operating Cash Flow147.57M
Free Cash Flow147.57M
Free Cash Flow per Share5.90
Dividends & Yields
AstraZeneca Pharma India Limited pays an annual dividend of ₹24, resulting in a dividend yield of 0.24%
Dividend Per Share₹24
Dividend Yield0.24%
Payout Ratio51.84%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.81
52-Week Price Change57.71%
50-Day Moving Average8.52K
200-Day Moving Average7.46K
Relative Strength Index (RSI)76.67
Average Volume (3m)4.79K
Important Dates
AstraZeneca Pharma India Limited upcoming earnings date is Aug 11, 2025, TBA Not Confirmed.
Last Earnings DateMay 30, 2025
Next Earnings DateAug 11, 2025
Ex-Dividend DateJul 05, 2024
Financial Position
AstraZeneca Pharma India Limited as a current ratio of 2.61, with Debt / Equity ratio of 2.52%
Current Ratio2.61
Quick Ratio1.97
Debt to Market Cap0.00
Net Debt to EBITDA-2.13
Interest Coverage Ratio372.82
Taxes
In the past 12 months, AstraZeneca Pharma India Limited has paid 580.30M in taxes.
Income Tax580.30M
Effective Tax Rate0.26
Enterprise Valuation
AstraZeneca Pharma India Limited EV to EBITDA ratio is 53.04, with an EV/FCF ratio of 730.60.
EV to Sales9.65
EV to EBITDA53.04
EV to Free Cash Flow730.60
EV to Operating Cash Flow448.53
Balance Sheet
AstraZeneca Pharma India Limited has ₹5.06B in cash and marketable securities with ₹0.00 in debt, giving a net cash position of -₹5.06B billion.
Cash & Marketable Securities₹5.06B
Total Debt₹0.00
Net Cash-₹5.06B
Net Cash Per Share-₹202.23
Tangible Book Value Per Share₹283.92
Margins
Gross margin is 35.54%, with operating margin of 34.53%, and net profit margin of 12.47%.
Gross Margin35.54%
Operating Margin34.53%
Pretax Margin16.95%
Net Profit Margin12.47%
EBITDA Margin18.19%
EBIT Margin17.04%
Analyst Forecast
The average price target for AstraZeneca Pharma India Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―